Webinar Date/Time: Wed, Sep 4, 2024 11:00 AM EDT
Join this joint Phenomenex and Quality Assistance webinar showcasing a groundbreaking 700 Å SEC column for AAV analysis. Discover the exceptional resolution of its monomer-aggregate separation and gain insights into evaluating CQAs like capsid load and much more to ensure the safety and efficacy of AAVs.
Register Free: https://www.chromatographyonline.com/lcgc_w/capsid-load
Event Overview:
AAVs are attractive vehicles for targeted drug delivery. There are numerous critical quality attributes (CQAs) that are evaluated to ensure the safety and efficacy of AAVs. Aggregation is a CQA and should be controlled, as AAVs are prone to aggregation from freeze-thaw cycles during storage.
In this webinar, we will explore CQAs using a novel size exclusion column optimal for AAV analysis, which enables the separation of AAV monomer from aggregate species with excellent peak shape, resolution, and peak profile to provide better data quality. Due to both the inert surface chemistry and flow path in the BiozenTM dSEC-7 column, the analysis conditions were independent of the serotype, showcasing the utilization of platform methodology.
In addition to calculating the aggregation level, aggregate molar mass, molar masses of protein and nucleic acid, and extinction coefficients of capsid and DNA were also determined. The novel particle chemistry of Biozen dSEC-7 provides instant stabilization of sensitive detectors like MALS to provide quality data.
Additionally, the full-to-empty capsid ratio was determined to accurately predict capsid load demonstrating Biozen dSEC-7’s utility as a holistic solution for the determination of CQAs of AAVs.
Key Learning Objectives:
Who Should Attend:
Speaker:
Ramkumar Dhandapani, PhD
Senior Product Manager
Phenomenex
Ramkumar Dhandapani, PhD, has been in the chromatography industry for over 20 years with hands-on and troubleshooting experience. He earned master’s and doctoral degrees in analytical chemistry from Seton Hall University with specialization in microextractions, multidimensional chromatography and tandem mass specs techniques. He has developed and validated several regulatory compliant methods in the pharmaceutical, food, fuels, and environmental industries and has incorporated method improvement and troubleshooting across a range of separation techniques. Dr Dhandapani joined Phenomenex in August 2014 and serves as a senior product manager. In addition to managing the product line, he presents on innovations in chromatography at various chromatography conferences.
Claire Butré, PhD
R&D Technical Leader
Quality Assistance
After earning an engineering degree in chemistry from the National Graduate School of Chemistry in Mulhouse, France, Claire Butré, PhD, earned her doctorate in the laboratory of food chemistry of Wageningen University & Research in the Netherlands, where she specialized in the analysis of proteins by mass spectrometry. She then worked at Wageningen University & Research as a researcher on several LC-MS method development projects for different applications. She joined Quality Assistance in 2018 as an R&D scientist and has been R&D technical leader since 2021. She and her team are involved in the development of new analytical techniques for the characterization of therapeutic proteins and new modalities (AAVs or mRNA), with a focus on liquid chromatography coupled to UV or MALS detectors and on mass spectrometry.
Register Free: https://www.chromatographyonline.com/lcgc_w/capsid-load
RAFA 2024 Highlights: Contemporary Food Contamination Analysis Using Chromatography
November 18th 2024A series of lectures focusing on emerging analytical techniques used to analyse food contamination took place on Wednesday 6 November 2024 at RAFA 2024 in Prague, Czech Republic. The session included new approaches for analysing per- and polyfluoroalkyl substances (PFAS), polychlorinated alkanes (PCAS), Mineral Oil Hydrocarbons (MOH), and short- and medium-chain chlorinated paraffins (SCCPs and MCCPs).
Advancing Bladder Cancer Research with Mass Spectrometry: A FeMS Interview with Marta Relvas-Santos
November 12th 2024LCGC International interviewed FeMS Empowerment Award winner Marta Relvas-Santos on her use of mass spectrometry to identify potential biomarkers and therapies for bladder cancer. She also shared insights on her work with FeMS and advice for fellow scientists.